IBX Stock: price and insider trades · Australia

IBX is a Health Care company. Its directors and officers file their transactions with ASX. The last twelve months, up to 18 October 2026, brought 2 filings signed by 1 insider.

The record shows 1 purchase on the open market, made by 1 insider, against 1 sale by 1 insider. The amount is not disclosed for 2 filings. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The buyers include 1 senior executive.

The last insider purchase was made public on 1 July 2026, 109 days ago.

Across the 2,530 companies tracked on its exchange, the median is 3 filings; at 2 filings, this issuer sits below that mark. Over the whole record (from 2026), the tally stands at 1 purchase and 1 sale.

Elsewhere in the same sector, our signals recently picked up insider purchases at Cooper Companies, Inc. and Cytosorbents Corp. This summary is built from ASX disclosures alone and does not predict where the share price will go.